Search by keywords: Connect with us Sloan Kettering @GSKGradSchool 522 News Items found Q&A Study Suggests New Ways of Manipulating Immune System to Treat Autoimmune Diseases and Cancer Friday, December 14, 2012 Recent findings by Memorial Sloan Kettering immunologists might one day pave the way for new strategies to control a range of diseases, including autoimmune disorders and cancer. Announcement Memorial Sloan Kettering Researchers Appointed to Stand Up To Cancer Immunology “Dream Team” Wednesday, December 12, 2012 Physician-scientists Michel Sadelain and Jedd Wolchok have been appointed to a new research team dedicated to investigating ways to harness the immune system to fight cancer. Q&A Developmental Biologist Lorenz Studer Comments on the 2012 Nobel Prize in Physiology or Medicine Tuesday, December 11, 2012 Methods to generate stem cells have given scientists new ways to study some diseases and identify potential drugs, and could one day be used to rebuild diseased or damaged tissues in patients. Announcement President Obama Names Physician-Scientist Charles Sawyers to National Cancer Advisory Board Saturday, December 8, 2012 Charles Sawyers, Chair of Memorial Sloan Kettering’s Human Oncology and Pathogenesis Program, is widely recognized as someone who is revolutionizing the molecular treatment of cancer. Q&A At Work: Biologist Scott Lowe, Chair of the Geoffrey Beene Cancer Research Center Monday, November 19, 2012 In the lab of cancer biologist Scott Lowe, researchers are investigating the processes that naturally inhibit cancer development. In the Lab New Imaging Agent Could Improve Prostate Cancer Diagnosis and Treatment Thursday, November 15, 2012 Researchers at Memorial Sloan Kettering are developing a new strategy for PET imaging of tumors that could result in new tools to detect and monitor prostate cancer. Q&A At Work: Physician-Scientist Ping Chi Friday, November 2, 2012 Dr. Chi, a physician-scientist and member of the Human Oncology and Pathogenesis Program, studies genetic and epigenetic changes that cause cancer. Announcement Pioneering Cancer Research Complex Nears Completion Wednesday, October 17, 2012 Memorial Sloan Kettering’s new research complex contains more than 100 laboratories, nearly doubling the space we dedicate to research to better understand and treat cancer. In the Lab Memorial Sloan Kettering Investigators Synthesize Vital Biological Molecule Erythropoietin for the First Time Monday, October 8, 2012 Researchers have produced a fully synthetic, functional version of erythropoietin, the hormone that controls production of red blood cells. Gerstner Sloan Kettering Students Receive Kirschstein Awards Monday, October 1, 2012 Four students have been awarded 2012 Ruth L. Kirschstein National Research Service Awards from the National Cancer Institute. Pagination Load More